Orthopedic Company Comes Under SEC Scrutiny

Law360 (November 21, 2006, 12:00 AM EST) -- Orthopedic products company ReGen Biologics Inc. said Monday that it has received a letter from the U.S. Securities and Exchange Commission’s Division of Enforcement requesting information regarding the company’s stock options-granting practices.

The investigation, disclosed in the company latest filing with the SEC, comes in the wake of the company restating past financial results.

ReGen said the SEC’s Nov. 16 letter requested “that the company preserve all documents concerning its granting of stock options to any of its executives or employees from January 2002 through the...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.